ASCO GU: Veracyte’s Decipher Tests Boost Cancer Care, Research
Study showing that Decipher GRID-derived PORTOS signature predicts benefit from dose-escalated radiation therapy also published in Annals of Oncology Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics...